Morghan Lucas is the co-lead of R&D at the Medical Genetics Centre (MGZ) Munich and a visiting scientist at the Ludwig Maximilian University of Munich (LMU) Hospital Clinic and LMU Friedrich Baur Institute (FBI). Her primary research focuses on developing molecular diagnostic tests for various diseases, including hereditary cancers and muscular dystrophy, with an emphasis on sequencing technologies. Prior to this, Morghan obtained her PhD at the Centre for Genomic Regulation (CRG) under the guidance of Dr. Eva Maria Novoa, where she developed various direct RNA nanopore sequencing-based methods, including RNA modification detection, short RNA sequencing, and multiplexing.